Corvus Pharmaceuticals, Inc.

Corvus Pharmaceuticals, Inc. financial statements

Corvus Pharmaceuticals, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 0EODHD
Net income−USD 15.28M10-K
Cash and equivalentsUSD 4.58M10-Q
Total debtUSD 937KEODHD

Corvus Pharmaceuticals, Inc. financials on 6ix · Corvus Pharmaceuticals, Inc. on 6ix